Investitionsthese
V-Bio Ventures co-creates startups and invests in early- to mid-stage companies with high growth potential, transforming scientific innovation into products that positively impact people’s lives by leveraging great science and empowering talented entrepreneurs.
Investitionsphase
Early/mid
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Early- to mid-stage companies with differentiated technology addressing unmet medical needs, focusing on drug discovery and development
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€77.700.000 - €77.850.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (12)
A
Aurelie Nowack
Principal
C
Christina Takke
Managing Partner
D
Dennis Pedri
Analyst
D
Dennis Pedri 2959Ab78
Team Member
K
Katja Rosenkranz
Partner
M
Marti Nsolleveld
Team Member
M
Mathias Falcenberg
Venture Partner
S
Shelley Margetson
Managing Partner
T
Tom Schwarz
Strategic Advisory Board Member
T
Tom Schwarz 283A57111
Team Member
W
Ward Capoen
Partner
W
Willem Broekaert
Managing Partner
